Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
BEDAQUILINE FUMARATE
(2012)
Small molecule
ATP synthase inhibitor
ORAL
Approved
Tuberculosis
BEDAQUILINE FUMARATE
×
Maximum Phase:
4
First Approval:
2012
UNII:
P04QX2C1A5
Molecule Type:
Small molecule
Molecular Formula:
C36H35BrN2O6
Molecular Weight:
671.59
AlogP:
7.13
PSA:
45.59
HBD:
1.0
HBA:
#RotB:
8.0
Source:
POMALIDOMIDE
(2013)
Small molecule
CRL4(CRBN) E3 ubiquitin ligase inhibitor
ORAL
Approved
Immune System Diseases; Multiple Myeloma
POMALIDOMIDE
×
Maximum Phase:
4
First Approval:
2013
UNII:
D2UX06XLB5
Molecule Type:
Small molecule
Molecular Formula:
C13H11N3O4
Molecular Weight:
273.25
AlogP:
-0.33
PSA:
109.57
HBD:
2.0
HBA:
#RotB:
1.0
Source:
VORTIOXETINE
(2013)
Small molecule
Unknown
ORAL
Approved
Depressive Disorder
VORTIOXETINE
×
Maximum Phase:
4
First Approval:
2013
UNII:
3O2K1S3WQV
Molecule Type:
Small molecule
Molecular Formula:
C18H22N2S
Molecular Weight:
298.46
AlogP:
3.86
PSA:
15.27
HBD:
1.0
HBA:
#RotB:
3.0
Source:
VILANTEROL
(2013)
Small molecule
Unknown
Unknown
Approved
Unknown
VILANTEROL
×
Maximum Phase:
4
First Approval:
2013
UNII:
028LZY775B
Molecule Type:
Small molecule
Molecular Formula:
C24H33Cl2NO5
Molecular Weight:
486.44
AlogP:
4.61
PSA:
91.18
HBD:
4.0
HBA:
#RotB:
16.0
Source:
TRAMETINIB DIMETHYL SULFOXIDE
(2013)
Small molecule
Dual specificity mitogen-activated protein kinase kinase 1 inhibitor
Unknown
Approved
Lung Neoplasms; Melanoma; Thyroid Neoplasms
TRAMETINIB DIMETHYL SULFOXIDE
×
Maximum Phase:
4
First Approval:
2013
UNII:
BSB9VJ5TUT
Molecule Type:
Small molecule
Molecular Formula:
C28H29FIN5O5S
Molecular Weight:
693.54
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
AFATINIB DIMALEATE
(2013)
Small molecule
Epidermal growth factor receptor erbB1 inhibitor
ORAL
Approved
Carcinoma, Non-Small-Cell Lung
AFATINIB DIMALEATE
×
Maximum Phase:
4
First Approval:
2013
UNII:
V1T5K7RZ0B
Molecule Type:
Small molecule
Molecular Formula:
C32H33ClFN5O11
Molecular Weight:
718.09
AlogP:
4.39
PSA:
88.61
HBD:
2.0
HBA:
#RotB:
8.0
Source:
VORTIOXETINE HYDROBROMIDE
(2013)
Small molecule
Serotonin 1a (5-HT1a) receptor agonist
ORAL
Approved
Depressive Disorder, Major
VORTIOXETINE HYDROBROMIDE
×
Maximum Phase:
4
First Approval:
2013
UNII:
TKS641KOAY
Molecule Type:
Small molecule
Molecular Formula:
C18H23BrN2S
Molecular Weight:
379.37
AlogP:
3.86
PSA:
15.27
HBD:
1.0
HBA:
#RotB:
3.0
Source:
ESOMEPRAZOLE STRONTIUM
(2013)
Small molecule
Potassium-transporting ATPase inhibitor
ORAL
Approved
Duodenal Ulcer; Gastroesophageal Reflux; Stomach Ulcer; Zollinger-Ellison Syndrome
ESOMEPRAZOLE STRONTIUM
×
Maximum Phase:
4
First Approval:
2013
UNII:
C5N25H3803
Molecule Type:
Small molecule
Molecular Formula:
C34H44N6O10S2Sr
Molecular Weight:
848.51
AlogP:
2.9
PSA:
77.1
HBD:
1.0
HBA:
#RotB:
5.0
Source:
SIMEPREVIR SODIUM
(2013)
Small molecule
Hepatitis C virus serine protease, NS3/NS4A inhibitor
ORAL
Approved
Unknown
SIMEPREVIR SODIUM
×
Maximum Phase:
4
First Approval:
2013
UNII:
16U7H60184
Molecule Type:
Small molecule
Molecular Formula:
C38H46N5NaO7S2
Molecular Weight:
771.94
AlogP:
5.25
PSA:
156.89
HBD:
2.0
HBA:
#RotB:
8.0
Source:
SOFOSBUVIR
(2013)
Small molecule
Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor
ORAL
Approved
Hepatitis C; Hepatitis C, Chronic; Virus Diseases
SOFOSBUVIR
×
Maximum Phase:
4
First Approval:
2013
UNII:
WJ6CA3ZU8B
Molecule Type:
Small molecule
Molecular Formula:
C22H29FN3O9P
Molecular Weight:
529.46
AlogP:
1.66
PSA:
158.18
HBD:
3.0
HBA:
#RotB:
10.0
Source:
LULICONAZOLE
(2013)
Small molecule
Cytochrome P450 51 inhibitor
TOPICAL
Approved
Tinea; Tinea Pedis
LULICONAZOLE
×
Maximum Phase:
4
First Approval:
2013
UNII:
RE91AN4S8G
Molecule Type:
Small molecule
Molecular Formula:
C14H9Cl2N3S2
Molecular Weight:
354.29
AlogP:
5.06
PSA:
41.61
HBD:
0.0
HBA:
#RotB:
2.0
Source:
NEOSTIGMINE
(2013)
Small molecule
Unknown
Unknown
Approved
Glaucoma
NEOSTIGMINE
×
Maximum Phase:
4
First Approval:
2013
UNII:
3982TWQ96G
Molecule Type:
Small molecule
Molecular Formula:
C12H19N2O2+
Molecular Weight:
223.3
AlogP:
1.94
PSA:
29.54
HBD:
0.0
HBA:
#RotB:
2.0
Source:
RADIUM DICHLORIDE
(2013)
Small molecule
Unknown
Unknown
Approved
Unknown
RADIUM DICHLORIDE
×
Maximum Phase:
4
First Approval:
2013
UNII:
KKO873WR2Z
Molecule Type:
Small molecule
Molecular Formula:
Cl2Ra
Molecular Weight:
296.91
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
FLUTEMETAMOL F 18
(2013)
Small molecule
Diagnostic agent
Unknown
Approved
Alzheimer Disease; Cognitive Dysfunction
FLUTEMETAMOL F 18
×
Maximum Phase:
4
First Approval:
2013
UNII:
L49M066S0O
Molecule Type:
Small molecule
Molecular Formula:
C14H11FN2OS
Molecular Weight:
273.32
AlogP:
3.85
PSA:
45.15
HBD:
2.0
HBA:
#RotB:
2.0
Source:
RIOCIGUAT
(2013)
Small molecule
Soluble guanylate cyclase positive allosteric modulator
ORAL
Approved
Familial Primary Pulmonary Hypertension; Hypertension; Hypertension, Pulmonary
RIOCIGUAT
×
Maximum Phase:
4
First Approval:
2013
UNII:
RU3FE2Y4XI
Molecule Type:
Small molecule
Molecular Formula:
C20H19FN8O2
Molecular Weight:
422.42
AlogP:
2.44
PSA:
138.07
HBD:
2.0
HBA:
#RotB:
4.0
Source:
VILANTEROL TRIFENATATE
(2013)
Small molecule
Beta-2 adrenergic receptor agonist
Unknown
Approved
Asthma; Bronchitis, Chronic; Emphysema; Pulmonary Disease, Chronic Obstructive
VILANTEROL TRIFENATATE
×
Maximum Phase:
4
First Approval:
2013
UNII:
40AHO2C6DG
Molecule Type:
Small molecule
Molecular Formula:
C44H49Cl2NO7
Molecular Weight:
774.78
AlogP:
4.61
PSA:
91.18
HBD:
4.0
HBA:
#RotB:
16.0
Source:
UMECLIDINIUM
(2013)
Small molecule
Unknown
Unknown
Approved
Unknown
UMECLIDINIUM
×
Maximum Phase:
4
First Approval:
2013
UNII:
GE2T1418SV
Molecule Type:
Small molecule
Molecular Formula:
C29H34NO2+
Molecular Weight:
428.6
AlogP:
5.14
PSA:
29.46
HBD:
1.0
HBA:
#RotB:
8.0
Source:
LEVOMILNACIPRAN
(2013)
Small molecule
Unknown
Unknown
Approved
Depressive Disorder
LEVOMILNACIPRAN
×
Maximum Phase:
4
First Approval:
2013
UNII:
UGM0326TXX
Molecule Type:
Small molecule
Molecular Formula:
C15H22N2O
Molecular Weight:
246.35
AlogP:
1.77
PSA:
46.33
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ALOGLIPTIN BENZOATE
(2013)
Small molecule
Dipeptidyl peptidase IV inhibitor
ORAL
Approved
Diabetes Mellitus, Type 2
ALOGLIPTIN BENZOATE
×
Maximum Phase:
4
First Approval:
2013
UNII:
EEN99869SC
Molecule Type:
Small molecule
Molecular Formula:
C25H27N5O4
Molecular Weight:
461.52
AlogP:
0.39
PSA:
97.05
HBD:
1.0
HBA:
#RotB:
3.0
Source:
DIMETHYL FUMARATE
(2013)
Small molecule
Kelch-like ECH-associated protein 1 inhibitor
ORAL
Approved
Immune System Diseases; Multiple Sclerosis
DIMETHYL FUMARATE
×
Maximum Phase:
4
First Approval:
2013
UNII:
FO2303MNI2
Molecule Type:
Small molecule
Molecular Formula:
C6H8O4
Molecular Weight:
144.13
AlogP:
-0.11
PSA:
52.6
HBD:
0.0
HBA:
#RotB:
2.0
Source:
SIMEPREVIR
(2013)
Small molecule
Unknown
Unknown
Approved
Hepatitis C, Chronic; Virus Diseases
SIMEPREVIR
×
Maximum Phase:
4
First Approval:
2013
UNII:
9WS5RD66HZ
Molecule Type:
Small molecule
Molecular Formula:
C38H47N5O7S2
Molecular Weight:
749.96
AlogP:
5.25
PSA:
156.89
HBD:
2.0
HBA:
#RotB:
8.0
Source:
DOLUTEGRAVIR SODIUM
(2013)
Small molecule
Human immunodeficiency virus type 1 integrase inhibitor
ORAL
Approved
HIV Infections
DOLUTEGRAVIR SODIUM
×
Maximum Phase:
4
First Approval:
2013
UNII:
1Q1V9V5WYQ
Molecule Type:
Small molecule
Molecular Formula:
C20H18F2N3NaO5
Molecular Weight:
441.37
AlogP:
1.35
PSA:
100.87
HBD:
2.0
HBA:
#RotB:
3.0
Source:
FLUTEMETAMOL
(2013)
Small molecule
Unknown
Unknown
Approved
Unknown
FLUTEMETAMOL
×
Maximum Phase:
4
First Approval:
2013
UNII:
0F3M7032P5
Molecule Type:
Small molecule
Molecular Formula:
C14H11FN2OS
Molecular Weight:
274.32
AlogP:
3.85
PSA:
45.15
HBD:
2.0
HBA:
#RotB:
2.0
Source:
GLYCEROL PHENYLBUTYRATE
(2013)
Small molecule
Glutamine sequestering agent
ORAL
Approved
Urea Cycle Disorders, Inborn
GLYCEROL PHENYLBUTYRATE
×
Maximum Phase:
4
First Approval:
2013
UNII:
ZH6F1VCV7B
Molecule Type:
Small molecule
Molecular Formula:
C33H38O6
Molecular Weight:
530.66
AlogP:
6.05
PSA:
78.9
HBD:
0.0
HBA:
#RotB:
17.0
Source:
DABRAFENIB
(2013)
Small molecule
Unknown
Unknown
Approved
Neoplasms
DABRAFENIB
×
Maximum Phase:
4
First Approval:
2013
UNII:
QGP4HA4G1B
Molecule Type:
Small molecule
Molecular Formula:
C23H20F3N5O2S2
Molecular Weight:
519.57
AlogP:
5.36
PSA:
110.86
HBD:
2.0
HBA:
#RotB:
5.0
Source:
AFATINIB
(2013)
Small molecule
Unknown
Unknown
Approved
Neoplasms
AFATINIB
×
Maximum Phase:
4
First Approval:
2013
UNII:
41UD74L59M
Molecule Type:
Small molecule
Molecular Formula:
C24H25ClFN5O3
Molecular Weight:
485.95
AlogP:
4.39
PSA:
88.61
HBD:
2.0
HBA:
#RotB:
8.0
Source:
TREPROSTINIL DIOLAMINE
(2013)
Small molecule
Prostanoid IP receptor agonist
ORAL
Approved
Unknown
TREPROSTINIL DIOLAMINE
×
Maximum Phase:
4
First Approval:
2013
UNII:
H1FKG90039
Molecule Type:
Small molecule
Molecular Formula:
C27H45NO7
Molecular Weight:
495.66
AlogP:
3.58
PSA:
86.99
HBD:
3.0
HBA:
#RotB:
10.0
Source:
DESVENLAFAXINE FUMARATE
(2013)
Small molecule
Norepinephrine transporter inhibitor
ORAL
Approved
Depressive Disorder, Major
DESVENLAFAXINE FUMARATE
×
Maximum Phase:
4
First Approval:
2013
UNII:
ATX24E9M6L
Molecule Type:
Small molecule
Molecular Formula:
C20H31NO7
Molecular Weight:
397.47
AlogP:
2.73
PSA:
43.7
HBD:
2.0
HBA:
#RotB:
4.0
Source:
OLIVE OIL
(2013)
Small molecule
Unknown
Unknown
Approved
Unknown
OLIVE OIL
×
Maximum Phase:
4
First Approval:
2013
UNII:
6UYK2W1W1E
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RADIUM RA 223 DICHLORIDE
(2013)
Small molecule
Radiotherapy agent
Unknown
Approved
Neoplasm Metastasis; Prostatic Neoplasms
RADIUM RA 223 DICHLORIDE
×
Maximum Phase:
4
First Approval:
2013
UNII:
RJ00KV3VTG
Molecule Type:
Small molecule
Molecular Formula:
Cl2Ra
Molecular Weight:
293.92
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
DABRAFENIB MESYLATE
(2013)
Small molecule
Serine/threonine-protein kinase B-raf inhibitor
ORAL
Approved
Melanoma; Thyroid Neoplasms
DABRAFENIB MESYLATE
×
Maximum Phase:
4
First Approval:
2013
UNII:
B6DC89I63E
Molecule Type:
Small molecule
Molecular Formula:
C24H24F3N5O5S3
Molecular Weight:
615.68
AlogP:
5.36
PSA:
110.86
HBD:
2.0
HBA:
#RotB:
5.0
Source:
UMECLIDINIUM BROMIDE
(2013)
Small molecule
Muscarinic acetylcholine receptor M3 antagonist
INHALATION
Approved
Bronchitis, Chronic; Emphysema; Lung Diseases, Obstructive; Pulmonary Disease, Chronic Obstructive
UMECLIDINIUM BROMIDE
×
Maximum Phase:
4
First Approval:
2013
UNII:
7AN603V4JV
Molecule Type:
Small molecule
Molecular Formula:
C29H34BrNO2
Molecular Weight:
508.5
AlogP:
5.14
PSA:
29.46
HBD:
1.0
HBA:
#RotB:
8.0
Source:
ALOGLIPTIN
(2013)
Small molecule
Unknown
Unknown
Approved
Diabetes Mellitus
ALOGLIPTIN
×
Maximum Phase:
4
First Approval:
2013
UNII:
JHC049LO86
Molecule Type:
Small molecule
Molecular Formula:
C18H21N5O2
Molecular Weight:
339.4
AlogP:
0.39
PSA:
97.05
HBD:
1.0
HBA:
#RotB:
3.0
Source:
GADOTERATE MEGLUMINE
(2013)
Small molecule
Diagnostic agent
INTRAVENOUS
Approved
Unknown
GADOTERATE MEGLUMINE
×
Maximum Phase:
4
First Approval:
2013
UNII:
L0ND3981AG
Molecule Type:
Small molecule
Molecular Formula:
C23H42GdN5O13
Molecular Weight:
753.86
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
OSPEMIFENE
(2013)
Small molecule
Estrogen receptor modulator
ORAL
Approved
Atrophy; Dyspareunia; Menopause
OSPEMIFENE
×
Maximum Phase:
4
First Approval:
2013
UNII:
B0P231ILBK
Molecule Type:
Small molecule
Molecular Formula:
C24H23ClO2
Molecular Weight:
378.9
AlogP:
5.65
PSA:
29.46
HBD:
1.0
HBA:
#RotB:
8.0
Source:
DOLUTEGRAVIR
(2013)
Small molecule
Unknown
ORAL
Approved
Virus Diseases
DOLUTEGRAVIR
×
Maximum Phase:
4
First Approval:
2013
UNII:
DKO1W9H7M1
Molecule Type:
Small molecule
Molecular Formula:
C20H19F2N3O5
Molecular Weight:
419.38
AlogP:
1.35
PSA:
100.87
HBD:
2.0
HBA:
#RotB:
3.0
Source:
1
2
…
62
63
64
65
66
67
68
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA